已收录 273530 条政策
 政策提纲
  • 暂无提纲
Commentary: Younger patients are choosing tissue valves: Do the data match their fervor?
[摘要] Over the past 5 years, there has been renewed discussion regarding the choice of bioprosthetic or mechanical valves for those undergoing surgical aortic valve replacement (SAVR).1-4 The choice of valve prosthesis should be based on several factors, including valve durability, expected hemodynamic parameters, surgical risk, the use of long-term anticoagulation therapy and its related bleeding risk, and patient values and preferences.5 The age range that remains a gray zone is between 50 and 65 years, and data on survival for this group are divergent.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 心脏病和心血管学
[关键词]  [时效性] 
   浏览次数:1      统一登录查看全文      激活码登录查看全文